Yiren Xiao
发表
J. Brooks,
D. Dill,
J. Leppert,
2020,
Proceedings of the National Academy of Sciences.
Yangqiu Li,
Suna Wang,
W. Ye,
2017,
Front. Immunol..
E. Rankin,
A. Giaccia,
Saravanan Nandagopal,
2021,
Clinical Cancer Research.
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian Cancer
E. Rankin,
A. Giaccia,
Saravanan Nandagopal,
2020,
bioRxiv.
Suna Wang,
Peng Li,
Xiaofang Sun,
2018,
mAbs.
E. Rankin,
A. Giaccia,
G. M. Cherf,
2021
.
Zhuo Wang,
E. Tatsis,
Ang Li,
2022,
Chemical science.
Yangqiu Li,
W. Ye,
P. Liu,
2015,
Journal of Hematology & Oncology.
J. Li,
W. Ye,
Peng Li,
2015,
Current cancer drug targets.
Yangqiu Li,
Suna Wang,
W. Ye,
2015,
Journal of Hematology & Oncology.
Yangqiu Li,
G. Qing,
Donghai Wu,
2015,
Haematologica.
Yangqiu Li,
Suna Wang,
W. Ye,
2016,
Oncotarget.
Peng Li,
P. Liu,
Peng Li,
2012,
Cell Regeneration.
J. Massagué,
C. Curtis,
S. Vanharanta,
2020,
Molecular Cancer Research.
M. Zeng,
Q. Zhong,
Z. Wen,
2015,
Oncotarget.
Yangqiu Li,
Suna Wang,
W. Ye,
2016,
Journal of Hematology & Oncology.
J. Brooks,
J. Leppert,
R. Nolley,
2019,
Cancer research.
E. Rankin,
A. Giaccia,
Q. Le,
2021,
The Journal of clinical investigation.
E. Rankin,
A. Enejder,
K. Fuh,
2021,
The Journal of clinical investigation.
Shouheng Lin,
Peng Li,
Yiren Xiao,
2015,
Stem cell investigation.
Jianxing He,
L. Ye,
Jianfei Shen,
2016,
Oncotarget.
E. Tatsis,
Zhuo Wang,
Yiren Xiao,
2022,
ACS Catalysis.